Evidence map›Paper›PMID 30792262›Full record

ArticleBioscience reports2019

High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.

Shuang Liu, Fanling Meng, Jing Ding, Hongying Ji, Mu Lin, Jiaqi Zhu, Rong Ma

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Multifaceted role ofMedComm · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shuang LiuDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Fanling MengDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Jing DingDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Hongying JiDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Mu LinDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Jiaqi ZhuDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Rong MaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China dr_marong2017@126.com.ORCID 0000-0001-8428-2989
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tripartite motif containing 44 (TRIM44) has been reported to be up-regulated in multiple aggressive malignant tumors. However, its expression status and clinical significance in cervical cancer remain unknown. The purpose of this study was to investigate the clinical significance of TRIM44 expression and the prognosis in patients with cervical cancer (CC). Fresh frozen tissues from 5 samples of CC and 4 normal cervical tissues were analyzed for TRIM44 expression using RT- PCR and Western blot analysis. 122 paraffin-embedded surgical specimens from patients with CC were collected for an immunohistochemistry. TRIM44 expression was found to be significantly up-regulated in cervical cancer specimens compared with adjacent normal tissues (

Indexed as

Gene Expression Regulation, NeoplasticBiomarkers, TumorCarcinoma, Squamous CellDisease ProgressionFemaleHumansIntracellular Signaling Peptides and ProteinsKaplan-Meier EstimateMiddle AgedMultivariate AnalysisPrognosisTripartite Motif ProteinsUterine Cervical NeoplasmsBiomarkers, TumorIntracellular Signaling Peptides and ProteinsTRIM44 protein, humanTripartite Motif ProteinsCervical cancerMetastasisPrognosisTRIM44

Identifiers

PMID30792262
PMCPMC6400662
OpenAlexW2917688731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.